Back to MORGAN STANLEY MORGAN STANLEY

AMLXAMLX
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in AMYLYX PHARMACEUTICALS INC

MORGAN STANLEY holds 3.1M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $56.2M as of 2026-Q2. The position was increased (+43.9% shares). AMLX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$56.2M

Current Shares

3.1M

Total Value Change

+$54.5M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+43.9%
$56.2M0.0%$17.96
40
2026-Q1
Decreased
2.2M
-7.8%
$30.2M0.0%$14.11
0
2025-Q4
Increased
2.4M
+21.0%
$28.5M0.0%$12.00
34
2025-Q3
Increased
2M
+300.6%
$26.5M0.0%$14.90
46
2025-Q2
Increased
486,893
+2.6%
$3.1M0.0%$6.33
27
2025-Q1
Increased
474,418
+2.2%
$1.7M0.0%$3.66
26
2024-Q4
Decreased
464,220
-2.9%
$1.8M0.0%$3.84
0
2024-Q3
Decreased
478,265
-48.3%
$1.5M0.0%$3.08
0
2024-Q2
New
924,459
-
$1.8M0.0%$1.90
36

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used